Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178445
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2023-12-11
Brief Title:
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization Data
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Class:
OTHER
Study ID:
TRAP-BTC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| MSD Sharp Dohme GmbH Germany | UNKNOWN |
| Medizinische Hochschule Hannover Germany Prof Dr Arndt Vogel | UNKNOWN |